What is Drucker Labs?
Drucker Labs specializes in advanced liquid supplements, leveraging proprietary Cold-Fill intraCELL Technology to deliver plant and soil-based microcomplexed minerals. Their product line, including intraMAX and intraMIN, utilizes Carbon-bond Technology to enhance bioavailability and support immune function. These supplements are designed for individuals seeking optimal health and are distributed exclusively through licensed health practitioners, ensuring a high standard of care and efficacy.
How much funding has Drucker Labs raised?
Drucker Labs has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Drucker Labs?
The substantial backing from this large-scale, late-stage funding round positions Drucker Labs for accelerated growth. This strategic investment will likely fuel further research and development into their unique mineral delivery systems, potentially expanding their product portfolio and market penetration. The company's focus on practitioner-led distribution suggests a strategy aimed at building trust and demonstrating clinical value, which could be further amplified by this new capital infusion. Future expansion may involve broader market access and enhanced production capabilities to meet growing demand for their specialized supplements.
See full Drucker Labs company page
